What is the Jubilant Ingrevia Ltd share price today?

The share price of NSE:JUBLINGREA-EQ on 07 Sep 2026 (as of 10:59:37 IST) is ₹680.00.

What is the NSE:JUBLINGREA-EQ 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the NSE:JUBLINGREA-EQ 52 week high low range shows a high of ₹795.00 and a low of ₹537.30.

What is the Jubilant Ingrevia Ltd market cap?

As on 07 Sep 2026, Jubilant Ingrevia Ltd market cap is ₹10849.40 Cr.

What is the shareholding pattern of Jubilant Ingrevia Ltd Stock?

The shareholding pattern of Jubilant Ingrevia Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 45.22% Foreign Institutional Investors (FII): 6.49% Domestic Institutional Investors (DII): 2.58% Mutual Funds: 22.39% Retail & Others: 23.32% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Jubilant Ingrevia Ltd?

The Price-to-Earnings (PE) ratio of Jubilant Ingrevia Ltd is 35.15, and the Price-to-Book (PB) ratio is 2.76, as on 07 Sep 2026.

Jubilant Ingrevia Share Price

635.35-5.60 (-0.87%)

-5.45% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-0.87%

1 Week

+1.67%

1 Month

-10.11%

3 Month

+2.20%

6 Month

+13.95%

YTD

-9.68%

1 Year

-5.45%

5 Year

-18.28%

10 Year

Max

+148.23%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

631.80

613.35

612.00

600.00

540.00

537.30

High

649.00

715.90

795.00

About

Jubilant Ingrevia Limited is a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with its customised products and solutions that are Read more

Chemicals

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SOLARINDSNSE

PIDILITINDNSE

SRFNSE

FLUOROCHEMNSE

NAVINFLUORNSE

GODREJINDNSE

DEEPAKNTRNSE

AETHERNSE

ATULNSE

AARTIINDNSE

JUBLINGREANSE

LTP

1W Low

1W High

Market cap (₹)

19480+925 (4.99%)

18730

20370

1,78,446Cr

1522-50.1 (-3.19%)

1517.50

1598

1,61,540Cr

2533.8+21.8 (0.87%)

2515.20

2563

75,295Cr

4471-115.7 (-2.52%)

4430.30

4610

49,109Cr

8446-144 (-1.68%)

8360

8650

43,357Cr

1091-16.4 (-1.48%)

1085.30

1117

37,273Cr

1600.9+14.6 (0.92%)

1570.10

1639

22,311Cr

1648+18 (1.10%)

1621.10

1663.90

21,914Cr

6135.5-35 (-0.57%)

6058.50

6234

18,016Cr

490.8-0.35 (-0.07%)

481.05

504.80

17,812Cr

634+9.1 (1.46%)

613.35

649

10,196Cr

Jubilant Ingrevia Share Price

635.35-5.60 (-0.87%)

-5.45% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years45%

3 years-3%

Last year5%

Compounded Profit Growth

10 years-

5 years39%

3 years-3%

Last year11%

Stock Price CAGR

10 years-

5 years-4%

3 years11%

1 year-5%

Return on Equity

10 years9%

5 years12%

3 years8%

Last year9%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	45%	-3%	5%
-	39%	-3%	11%
-	-4%	11%	-5%
9%	12%	8%	9%

Peer Comparison

Symbol

SOLARINDS

PIDILITIND

SRF

FLUOROCHEM

NAVINFLUOR

GODREJIND

DEEPAKNTR

AETHER

ATUL

AARTIIND

JUBLINGREA

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
19,480	₹178446 Cr	89.61	72.11	250.42	₹1678 Cr
1,522	₹161540 Cr	60.98	8.57	29.89	₹2449 Cr
2,533.8	₹75295 Cr	34.83	25.6	102.33	₹1835 Cr
4,471	₹49109 Cr	79.85	20.09	90.49	₹577 Cr
8,446	₹43357 Cr	54.9	47.43	184.25	₹664 Cr
1,091	₹37273 Cr	31.7	8.44	50.37	₹1241 Cr
1,600.9	₹22311 Cr	28.48	25.29	74.81	₹551 Cr
1,648	₹21914 Cr	93.18	4.73	23.27	₹219 Cr
6,135.5	₹18016 Cr	22.65	83.32	378.24	₹678 Cr
490.8	₹17812 Cr	33.54	4.28	27.98	₹419 Cr
634	₹10196 Cr	33.04	6.71	31.03	₹278 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021
₹1300 Cr	₹1179 Cr	₹1051 Cr	₹1121 Cr	₹1038 Cr	₹1051 Cr	₹1057 Cr	₹1045 Cr	₹1024 Cr	₹1074 Cr	₹966 Cr	₹1020 Cr	₹1075 Cr	₹1145 Cr	₹1158 Cr	₹1304 Cr	₹1166 Cr	₹1296 Cr	₹1286 Cr	₹1223 Cr	₹1145 Cr	₹684 Cr
₹10 Cr	₹9 Cr	₹9 Cr	₹11 Cr	₹11 Cr	₹8 Cr	₹9 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹7 Cr	₹7 Cr	₹10 Cr	₹9 Cr	₹9 Cr	₹7 Cr	₹6 Cr	₹3 Cr
₹1310 Cr	₹1188 Cr	₹1060 Cr	₹1132 Cr	₹1049 Cr	₹1060 Cr	₹1066 Cr	₹1056 Cr	₹1034 Cr	₹1084 Cr	₹975 Cr	₹1028 Cr	₹1084 Cr	₹1154 Cr	₹1165 Cr	₹1311 Cr	₹1176 Cr	₹1305 Cr	₹1296 Cr	₹1230 Cr	₹1151 Cr	₹687 Cr
₹1152 Cr	₹1064 Cr	₹969 Cr	₹1026 Cr	₹937 Cr	₹944 Cr	₹958 Cr	₹960 Cr	₹954 Cr	₹1019 Cr	₹905 Cr	₹936 Cr	₹991 Cr	₹1073 Cr	₹1037 Cr	₹1182 Cr	₹1056 Cr	₹1184 Cr	₹1104 Cr	₹1058 Cr	₹895 Cr	₹589 Cr
₹209 Cr	₹172 Cr	₹136 Cr	₹146 Cr	₹153 Cr	₹155 Cr	₹148 Cr	₹135 Cr	₹119 Cr	₹101 Cr	₹104 Cr	₹126 Cr	₹125 Cr	₹111 Cr	₹158 Cr	₹160 Cr	₹151 Cr	₹152 Cr	₹222 Cr	₹202 Cr	₹287 Cr	₹120 Cr
₹17 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹13 Cr	₹14 Cr	₹12 Cr	₹15 Cr	₹14 Cr	₹14 Cr	₹15 Cr	₹13 Cr	₹11 Cr	₹6 Cr	₹7 Cr	₹5 Cr	₹4 Cr	₹6 Cr	₹5 Cr	₹7 Cr	₹13 Cr	₹7 Cr
₹141 Cr	₹112 Cr	₹65 Cr	₹93 Cr	₹100 Cr	₹102 Cr	₹96 Cr	₹80 Cr	₹66 Cr	₹51 Cr	₹55 Cr	₹80 Cr	₹81 Cr	₹76 Cr	₹122 Cr	₹124 Cr	₹116 Cr	₹115 Cr	₹187 Cr	₹165 Cr	₹243 Cr	₹77 Cr
₹106 Cr	₹86 Cr	₹47 Cr	₹70 Cr	₹75 Cr	₹74 Cr	₹69 Cr	₹59 Cr	₹49 Cr	₹29 Cr	₹39 Cr	₹57 Cr	₹58 Cr	₹52 Cr	₹92 Cr	₹84 Cr	₹79 Cr	₹69 Cr	₹129 Cr	₹111 Cr	₹168 Cr	₹54 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
—	—	—	—	—	—	—
₹16 Cr	₹16 Cr	₹16 Cr	₹16 Cr	₹16 Cr	₹16 Cr	₹5 L
₹25 Cr	₹17 Cr	₹10 Cr	₹4 Cr	₹1 Cr	₹0	₹0
₹3086 Cr	₹2894 Cr	₹2712 Cr	₹2646 Cr	₹2416 Cr	₹1907 Cr	-₹17 L
₹3086 Cr	₹2894 Cr	₹2712 Cr	₹2646 Cr	₹2416 Cr	₹1907 Cr	-₹17 L
₹3126 Cr	₹2927 Cr	₹2737 Cr	₹2666 Cr	₹2433 Cr	₹1923 Cr	-₹12 L
₹322 Cr	₹363 Cr	₹426 Cr	₹150 Cr	₹100 Cr	₹456 Cr	₹0
₹228 Cr	₹208 Cr	₹201 Cr	₹180 Cr	₹122 Cr	₹15 Cr	₹0
₹129 Cr	₹49 Cr	₹4 Cr	₹7 Cr	₹7 Cr	₹8 Cr	₹0
₹73 Cr	₹67 Cr	₹65 Cr	₹66 Cr	₹68 Cr	₹69 Cr	₹0
₹752 Cr	₹687 Cr	₹696 Cr	₹403 Cr	₹296 Cr	₹549 Cr	₹0
—	—	—	—	—	—	—
₹941 Cr	₹815 Cr	₹767 Cr	₹801 Cr	₹798 Cr	₹694 Cr	₹17 L
₹273 Cr	₹232 Cr	₹195 Cr	₹110 Cr	₹102 Cr	₹183 Cr	₹0
₹342 Cr	₹304 Cr	₹283 Cr	₹247 Cr	₹129 Cr	₹0	₹0
₹36 Cr	₹50 Cr	₹41 Cr	₹22 Cr	₹24 Cr	₹17 Cr	₹0
₹1592 Cr	₹1401 Cr	₹1286 Cr	₹1180 Cr	₹1053 Cr	₹894 Cr	₹17 L
₹5470 Cr	₹5015 Cr	₹4719 Cr	₹4249 Cr	₹3782 Cr	₹3366 Cr	₹5 L
₹463 Cr	₹361 Cr	₹413 Cr	₹354 Cr	₹353 Cr	₹294 Cr	₹0
₹781 Cr	₹757 Cr	₹733 Cr	₹397 Cr	₹229 Cr	₹545 Cr	₹0
—	—	—	—	—	—	—
₹4371 Cr	₹3617 Cr	₹3444 Cr	₹2626 Cr	₹2463 Cr	₹2353 Cr	₹0
₹1187 Cr	₹1036 Cr	₹905 Cr	₹780 Cr	₹665 Cr	₹548 Cr	₹0
₹3183 Cr	₹2581 Cr	₹2539 Cr	₹1846 Cr	₹1798 Cr	₹1805 Cr	₹0
₹154 Cr	₹525 Cr	₹331 Cr	₹525 Cr	₹169 Cr	₹63 Cr	₹0
₹33 Cr	₹21 Cr	₹15 Cr	₹8 Cr	₹6 Cr	₹50 Cr	₹0
₹33 Cr	₹21 Cr	₹15 Cr	₹8 Cr	₹6 Cr	₹50 Cr	₹0
₹32 Cr	₹24 Cr	₹37 Cr	₹43 Cr	₹26 Cr	₹22 Cr	₹0
₹21 Cr	₹11 Cr	₹16 Cr	₹9 Cr	₹13 Cr	₹50 L	₹0
₹3423 Cr	₹3162 Cr	₹2939 Cr	₹2431 Cr	₹2018 Cr	₹1943 Cr	₹0
—	—	—	—	—	—	—
₹0	₹16 Cr	₹0	₹0	₹0	₹0	₹0
₹880 Cr	₹943 Cr	₹941 Cr	₹1035 Cr	₹911 Cr	₹609 Cr	₹0
₹783 Cr	₹607 Cr	₹572 Cr	₹511 Cr	₹581 Cr	₹471 Cr	₹0
₹190 Cr	₹99 Cr	₹80 Cr	₹85 Cr	₹49 Cr	₹117 Cr	₹5 L
₹59 Cr	₹52 Cr	₹48 Cr	₹39 Cr	₹83 Cr	₹75 Cr	₹0
₹135 Cr	₹135 Cr	₹140 Cr	₹148 Cr	₹141 Cr	₹152 Cr	₹0
₹2046 Cr	₹1853 Cr	₹1780 Cr	₹1818 Cr	₹1765 Cr	₹1424 Cr	₹5 L
₹455 Cr	₹452 Cr	₹494 Cr	₹638 Cr	₹712 Cr	₹529 Cr	-₹12 L
₹5470 Cr	₹5015 Cr	₹4719 Cr	₹4249 Cr	₹3782 Cr	₹3366 Cr	₹5 L
₹197	₹184	₹173	₹167	₹153	₹121	-₹2
₹197	₹184	₹173	₹167	₹153	₹121	-₹2

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
₹370 Cr	₹344 Cr	₹268 Cr	₹437 Cr	₹709 Cr	₹77 Cr	-₹17 L
₹257 Cr	₹221 Cr	₹203 Cr	₹148 Cr	₹174 Cr	₹45 Cr	₹0
₹1 Cr	₹23 Cr	₹6 Cr	-₹45 Cr	-₹302 Cr	₹95 L	₹17 L
₹628 Cr	₹588 Cr	₹476 Cr	₹540 Cr	₹581 Cr	₹124 Cr	₹0
₹524 Cr	₹508 Cr	₹430 Cr	₹462 Cr	₹453 Cr	₹112 Cr	₹0
-₹276 Cr	-₹393 Cr	-₹569 Cr	-₹472 Cr	-₹72 Cr	-₹44 Cr	₹0
-₹155 Cr	-₹129 Cr	₹144 Cr	₹42 Cr	-₹418 Cr	-₹72 Cr	₹5 L
₹93 Cr	-₹13 Cr	₹5 Cr	₹32 Cr	-₹37 Cr	-₹4 Cr	₹5 L
₹69 Cr	₹79 Cr	₹73 Cr	₹38 Cr	₹73 Cr	₹5 L	₹0
₹0	₹0	₹0	₹0	₹0	₹77 Cr	₹0
₹7 L	₹0	₹0	₹0	₹0	₹0	₹0
₹26 Cr	₹4 Cr	₹72 L	₹3 Cr	₹1 Cr	₹10 L	₹0
₹188 Cr	₹69 Cr	₹79 Cr	₹73 Cr	₹38 Cr	₹73 Cr	₹5 L

Fundamental Ratios

Consolidated

Standalone

Jubilant Ingrevia Share Price

635.35-5.60 (-0.87%)

-5.45% past 1 Year

Shareholding summary

Promoters

45.22%

FII

6.49%

DII

2.58%

22.39%

Others

23.32%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
45.22%	45.22%	45.22%	45.22%	45.22%	51.47%
6.49%	6.49%	6.15%	5.96%	6.96%	7.12%
2.58%	2.54%	2.53%	2.62%	2.23%	1.80%
22.39%	22.21%	21.46%	20.41%	19.57%	14.10%
23.32%	23.54%	24.64%	25.79%	26.02%	25.51%

Bulk & block deals

Name

Kotak Mahindra Mutual Fund

Hdfc Mutual Fund

Axis Mutual Fund

Graviton Research Capital Llp

Musigma Securities

Shyam Sunder Bhartia Family Trust

Nikita Resources Private Limited

Jubilant Enpro Private Limited

Graviton Research Capital Llp

Musigma Securities

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
13 Jun 2025	Purchase	301.84 Cr	₹676	44.65 L	Bulk	2.803265	NSE
13 Jun 2025	Purchase	133.17 Cr	₹676	19.70 L	Bulk	1.236807	NSE
13 Jun 2025	Purchase	128.44 Cr	₹676	19 L	Bulk	1.19286	NSE
13 Jun 2025	Purchase	91.14 Cr	₹749.36	12.16 L	Bulk	0.763576	NSE
13 Jun 2025	Purchase	75.50 Cr	₹772.36	9.78 L	Bulk	0.613716	NSE
13 Jun 2025	Sell	244.95 Cr	₹676	36.23 L	Bulk	2.274884	NSE
13 Jun 2025	Sell	230.82 Cr	₹676	34.15 L	Bulk	2.14372	NSE
13 Jun 2025	Sell	191.11 Cr	₹676	28.27 L	Bulk	1.774894	NSE
13 Jun 2025	Sell	91.28 Cr	₹750.53	12.16 L	Bulk	0.763576	NSE
13 Jun 2025	Sell	75.52 Cr	₹772.56	9.78 L	Bulk	0.613716	NSE

Insider trading & SAST

Client name

Jubilant Ingrevia Employees Welfare Trust

Hsb Trustee Company Private Ltd And Hs Trustee Company Pvt Ltd

Hsb Trustee Company Private Limited And Hs Trustee Company Private Limited (Jointly Acting As Trustee On Behalf Of Hari Shanker Bhartia Family Trust

Jubilant Ingrevia Employees Welfare Trust

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
18 Sep 2026	Trust	Disposal	0.005529	0.96	55.77 L	₹633.25	8.81 K	17 Sep 2026	ESOP	15,22,601	Insider Trading	—	Equity
14 Sep 2026	Trust	Disposal	0.001624	0.96	17.03 L	₹658.40	2.59 K	11 Sep 2026	ESOP	15,31,408	Insider Trading	—	Equity
01 Sep 2026	Trust	Disposal	0.00353	0.96	38.43 L	₹683.50	5.62 K	28 Aug 2026	ESOP	15,33,995	Insider Trading	—	Equity
25 Aug 2026	Trust	Disposal	0.001649	0.97	18.61 L	₹708.25	2.63 K	21 Aug 2026	ESOP	15,39,617	Insider Trading	—	Equity
17 Aug 2026	Trust	Disposal	0.008253	0.97	97.02 L	₹738	13.15 K	14 Aug 2026	ESOP	15,42,244	Insider Trading	—	Equity
12 Aug 2026	Trust	Disposal	0.005776	0.98	67.45 L	₹733.10	9.20 K	11 Aug 2026	ESOP	15,55,390	Insider Trading	—	Equity
30 Jun 2026	Promoter	Pledge	—	—	0	—	6 L	17 Jun 2026	Creation	33,50,000	SAST	Reg31	—
28 Mar 2026	Promoter	Pledge	—	—	0	—	2 L	23 Mar 2026	Creation	27,50,000	SAST	Reg31	—
23 Mar 2026	Trust	Acquisition	0.006278	0.98	56.21 L	₹562.09	10 K	23 Mar 2026	Market Purchase	15,64,590	Insider Trading	—	Equity Shares
20 Mar 2026	Trust	Acquisition	0.015696	0.98	1.45 Cr	₹581.66	25 K	20 Mar 2026	Market Purchase	15,54,590	Insider Trading	—	Equity Shares

Jubilant Ingrevia Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Jubilant Ingrevia Share Price

Jubilant Ingrevia Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Jubilant Ingrevia Share Price

Jubilant Ingrevia Share Price

Oscillators

Moving averages

Jubilant Ingrevia Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Jubilant Ingrevia Share Price

Corporate Actions

Company details

Jubilant Ingrevia Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Jubilant Ingrevia Share Price

News

Jubilant Ingrevia to acquire 40 percent in Zettaone Technologies India for expansion

Jubilant Ingrevia board approves 40 percent stake purchase in Zettaone Technologies

Jubilant Ingrevia ramps niacinamide, specialty chemicals and nutrition EBITDA mix

Jubilant Ingrevia maintains FY27 EBITDA guidance amid expected sequential recovery

Jubilant Ingrevia Q1 FY26 EBITDA jumps with improved margin performance

Jubilant Ingrevia Q1 revenue rises year-on-year, indicating healthy topline momentum

Jubilant Ingrevia Q1 consolidated net profit jumps sharply on YoY basis

Jubilant Ingrevia Ltd.: Rs 16.70 Crores Nse Block Trade; For ~ 261,366 Shares, At Rs 638.85

Incred Maintains Add On Rating on Jubilant Ingrevia, Cuts Target Price

Jubilant Ingrevia informs about compliance report

Jubilant Ingrevia guides for strong sequential growth in FY27 performance

Jubilant Ingrevia outlines FY27 capex, reaffirms long-term growth and earnings targets

Jubilant Ingrevia projects strong revenue ramp-up from new CDMO opportunities

Jubilant Ingrevia outlines strong multi-business volume and new molecule pipeline

Jubilant Ingrevia - Quaterly Results

Jubilant Ingrevia reports Profit after tax of 105.22 Crores, in the March 2026 quarter

Jubilant Ingrevia Q4 EBITDA grows year-on-year despite slight margin compression

Jubilant Ingrevia reports higher Q4 revenue on year,

Jubilant Ingrevia reports higher Q4 consolidated net profit year on year

Jubilant Ingrevia zooms on acquiring 100% equity stake in Remidex Pharma

Jubilant Ingrevia Ltd Share Price Today

Jubilant Ingrevia Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator